{
  "fullName": "Alexander Fleming",
  "slug": "alexander-fleming",
  "title": "MD",
  "specialty": "Microbiology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 142,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Sir Alexander Fleming was a Scottish physician and microbiologist. He shared the 1945 Nobel Prize in Physiology or Medicine with Howard Florey and Ernst Chain \"for the discovery of penicillin and its curative effect in various infectious diseases\".\nThis was the first antibiotic substance discovered. His discovery in 1928 of what was later named benzylpenicillin from the mould Penicillium rubens has been described as the \"single greatest victory ever achieved over disease\".",
  "aiSummary": "Alexander Fleming is a microbiology specialist with an H-index of 142 at St Mary’s Hospital London (Member). Has been published in New England Journal of Medicine, The Lancet, BMJ. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "St Mary’s Hospital London"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "St Mary’s Hospital London",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Microbiology"
  ],
  "knowsAbout": [
    "Nobel Prize in Physiology or Medicine"
  ],
  "citations": [
    {
      "title": "Effects of Intensive Glucose Lowering in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2008,
      "citationCount": 7775,
      "doi": "10.1056/nejmoa0802743",
      "sourceUrl": "https://doi.org/10.1056/nejmoa0802743",
      "verified": true
    },
    {
      "title": "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2016,
      "citationCount": 6956,
      "doi": "10.1056/nejmoa1603827",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1603827",
      "verified": true
    },
    {
      "title": "Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetologia",
      "year": 2012,
      "citationCount": 3928,
      "doi": "10.1007/s00125-012-2534-0",
      "sourceUrl": "https://doi.org/10.1007/s00125-012-2534-0",
      "verified": true
    },
    {
      "title": "Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy",
      "journal": "Diabetes Care",
      "year": 2008,
      "citationCount": 3821,
      "doi": "10.2337/dc08-9025",
      "sourceUrl": "https://doi.org/10.2337/dc08-9025",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetes Care",
      "year": 2018,
      "citationCount": 3421,
      "doi": "10.2337/dci18-0033",
      "sourceUrl": "https://doi.org/10.2337/dci18-0033",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach",
      "journal": "Diabetes Care",
      "year": 2012,
      "citationCount": 3195,
      "doi": "10.2337/dc12-0413",
      "sourceUrl": "https://doi.org/10.2337/dc12-0413",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes",
      "journal": "Diabetes Care",
      "year": 2014,
      "citationCount": 3047,
      "doi": "10.2337/dc14-2441",
      "sourceUrl": "https://doi.org/10.2337/dc14-2441",
      "verified": true
    },
    {
      "title": "Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2015,
      "citationCount": 2540,
      "doi": "10.1056/nejmoa1501352",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1501352",
      "verified": true
    },
    {
      "title": "The Metabolic Syndrome: Time for a Critical Appraisal",
      "journal": "Diabetes Care",
      "year": 2005,
      "citationCount": 2379,
      "doi": "10.2337/diacare.28.9.2289",
      "sourceUrl": "https://doi.org/10.2337/diacare.28.9.2289",
      "verified": true
    },
    {
      "title": "Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 2045,
      "doi": "10.1056/nejmoa1612917",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1612917",
      "verified": true
    },
    {
      "title": "Strategies for Multivessel Revascularization in Patients with Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2012,
      "citationCount": 1860,
      "doi": "10.1056/nejmoa1211585",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1211585",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetes Care",
      "year": 2022,
      "citationCount": 1739,
      "doi": "10.2337/dci22-0034",
      "sourceUrl": "https://doi.org/10.2337/dci22-0034",
      "verified": true
    },
    {
      "title": "Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)",
      "journal": "The Lancet",
      "year": 2009,
      "citationCount": 1475,
      "doi": "10.1016/s0140-6736(09)60659-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(09)60659-0",
      "verified": true
    },
    {
      "title": "Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetologia",
      "year": 2018,
      "citationCount": 1440,
      "doi": "10.1007/s00125-018-4729-5",
      "sourceUrl": "https://doi.org/10.1007/s00125-018-4729-5",
      "verified": true
    },
    {
      "title": "Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes",
      "journal": "Diabetes Care",
      "year": 2004,
      "citationCount": 1335,
      "doi": "10.2337/diacare.27.11.2628",
      "sourceUrl": "https://doi.org/10.2337/diacare.27.11.2628",
      "verified": true
    },
    {
      "title": "Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy",
      "journal": "Diabetes Care",
      "year": 2006,
      "citationCount": 1208,
      "doi": "10.2337/dc06-9912",
      "sourceUrl": "https://doi.org/10.2337/dc06-9912",
      "verified": true
    },
    {
      "title": "Liraglutide and Renal Outcomes in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 1179,
      "doi": "10.1056/nejmoa1616011",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1616011",
      "verified": true
    },
    {
      "title": "2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetes Care",
      "year": 2019,
      "citationCount": 1150,
      "doi": "10.2337/dci19-0066",
      "sourceUrl": "https://doi.org/10.2337/dci19-0066",
      "verified": true
    },
    {
      "title": "Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus",
      "journal": "Diabetes Care",
      "year": 2006,
      "citationCount": 1058,
      "doi": "10.2337/dc07-9917",
      "sourceUrl": "https://doi.org/10.2337/dc07-9917",
      "verified": true
    },
    {
      "title": "Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study",
      "journal": "The Lancet",
      "year": 2008,
      "citationCount": 1057,
      "doi": "10.1016/s0140-6736(08)61206-4",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(08)61206-4",
      "verified": true
    },
    {
      "title": "How Do We Define Cure of Diabetes?",
      "journal": "Diabetes Care",
      "year": 2009,
      "citationCount": 985,
      "doi": "10.2337/dc09-9036",
      "sourceUrl": "https://doi.org/10.2337/dc09-9036",
      "verified": true
    },
    {
      "title": "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study",
      "journal": "BMJ",
      "year": 2010,
      "citationCount": 918,
      "doi": "10.1136/bmj.b4909",
      "sourceUrl": "https://doi.org/10.1136/bmj.b4909",
      "verified": true
    },
    {
      "title": "Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetologia",
      "year": 2022,
      "citationCount": 900,
      "doi": "10.1007/s00125-022-05787-2",
      "sourceUrl": "https://doi.org/10.1007/s00125-022-05787-2",
      "verified": true
    },
    {
      "title": "Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2010,
      "citationCount": 884,
      "doi": "10.1056/nejmoa1002853",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1002853",
      "verified": true
    },
    {
      "title": "Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials",
      "journal": "Diabetes Care",
      "year": 2008,
      "citationCount": 881,
      "doi": "10.2337/dc08-9026",
      "sourceUrl": "https://doi.org/10.2337/dc08-9026",
      "verified": true
    },
    {
      "title": "Molecular Biology of Mammalian Glucose Transporters",
      "journal": "Diabetes Care",
      "year": 1990,
      "citationCount": 871,
      "doi": "10.2337/diacare.13.3.198",
      "sourceUrl": "https://doi.org/10.2337/diacare.13.3.198",
      "verified": true
    },
    {
      "title": "Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)",
      "journal": "Diabetes Care",
      "year": 2009,
      "citationCount": 834,
      "doi": "10.2337/dc08-2124",
      "sourceUrl": "https://doi.org/10.2337/dc08-2124",
      "verified": true
    },
    {
      "title": "Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition",
      "journal": "Diabetes Care",
      "year": 2015,
      "citationCount": 807,
      "doi": "10.2337/dc15-0843",
      "sourceUrl": "https://doi.org/10.2337/dc15-0843",
      "verified": true
    },
    {
      "title": "Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379",
      "journal": "Diabetes Care",
      "year": 2013,
      "citationCount": 807,
      "doi": "10.2337/dc13-er02",
      "sourceUrl": "https://doi.org/10.2337/dc13-er02",
      "verified": true
    },
    {
      "title": "Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2015,
      "citationCount": 802,
      "doi": "10.1073/pnas.1505405112",
      "sourceUrl": "https://doi.org/10.1073/pnas.1505405112",
      "verified": true
    },
    {
      "title": "A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia",
      "journal": "Diabetes Care",
      "year": 2005,
      "citationCount": 795,
      "doi": "10.2337/diacare.28.7.1547",
      "sourceUrl": "https://doi.org/10.2337/diacare.28.7.1547",
      "verified": true
    },
    {
      "title": "Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection",
      "journal": "JAMA",
      "year": 2023,
      "citationCount": 788,
      "doi": "10.1001/jama.2023.8823",
      "sourceUrl": "https://doi.org/10.1001/jama.2023.8823",
      "verified": true
    },
    {
      "title": "Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy",
      "journal": "Diabetologia",
      "year": 2008,
      "citationCount": 713,
      "doi": "10.1007/s00125-008-1157-y",
      "sourceUrl": "https://doi.org/10.1007/s00125-008-1157-y",
      "verified": true
    },
    {
      "title": "Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years",
      "journal": "Current Medical Research and Opinion",
      "year": 2007,
      "citationCount": 698,
      "doi": "10.1185/030079908x253870",
      "sourceUrl": "https://doi.org/10.1185/030079908x253870",
      "verified": true
    },
    {
      "title": "Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes",
      "journal": "Diabetologia",
      "year": 2015,
      "citationCount": 683,
      "doi": "10.1007/s00125-014-3460-0",
      "sourceUrl": "https://doi.org/10.1007/s00125-014-3460-0",
      "verified": true
    },
    {
      "title": "Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events",
      "journal": "New England Journal of Medicine",
      "year": 2010,
      "citationCount": 664,
      "doi": "10.1056/nejmoa1001121",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1001121",
      "verified": true
    },
    {
      "title": "Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods",
      "journal": "The American Journal of Cardiology",
      "year": 2007,
      "citationCount": 644,
      "doi": "10.1016/j.amjcard.2007.03.003",
      "sourceUrl": "https://doi.org/10.1016/j.amjcard.2007.03.003",
      "verified": true
    },
    {
      "title": "Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus",
      "journal": "Circulation",
      "year": 2006,
      "citationCount": 632,
      "doi": "10.1161/circulationaha.106.179294",
      "sourceUrl": "https://doi.org/10.1161/circulationaha.106.179294",
      "verified": true
    },
    {
      "title": "Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis",
      "journal": "The Lancet Diabetes & Endocrinology",
      "year": 2017,
      "citationCount": 563,
      "doi": "10.1016/s2213-8587(17)30412-6",
      "sourceUrl": "https://doi.org/10.1016/s2213-8587(17)30412-6",
      "verified": true
    },
    {
      "title": "Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs",
      "journal": "Nature Biomedical Engineering",
      "year": 2020,
      "citationCount": 561,
      "doi": "10.1038/s41551-019-0508-y",
      "sourceUrl": "https://doi.org/10.1038/s41551-019-0508-y",
      "verified": true
    },
    {
      "title": "Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study",
      "journal": "The Lancet",
      "year": 2012,
      "citationCount": 558,
      "doi": "10.1016/s0140-6736(12)61267-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(12)61267-7",
      "verified": true
    },
    {
      "title": "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 556,
      "doi": "10.1056/nejmoa1615692",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1615692",
      "verified": true
    },
    {
      "title": "Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes",
      "journal": "The Journal of Clinical Endocrinology & Metabolism",
      "year": 2003,
      "citationCount": 551,
      "doi": "10.1210/jc.2002-021545",
      "sourceUrl": "https://doi.org/10.1210/jc.2002-021545",
      "verified": true
    },
    {
      "title": "The soluble interleukin‐6 receptor is generated by shedding",
      "journal": "European Journal of Immunology",
      "year": 1993,
      "citationCount": 508,
      "doi": "10.1002/eji.1830230226",
      "sourceUrl": "https://doi.org/10.1002/eji.1830230226",
      "verified": true
    },
    {
      "title": "Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes",
      "journal": "Annals of Internal Medicine",
      "year": 2011,
      "citationCount": 503,
      "doi": "10.7326/0003-4819-154-2-201101180-00300",
      "sourceUrl": "https://doi.org/10.7326/0003-4819-154-2-201101180-00300",
      "verified": true
    },
    {
      "title": "2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)",
      "journal": "Diabetologia",
      "year": 2019,
      "citationCount": 492,
      "doi": "10.1007/s00125-019-05039-w",
      "sourceUrl": "https://doi.org/10.1007/s00125-019-05039-w",
      "verified": true
    },
    {
      "title": "Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues",
      "journal": "Journal of Biological Chemistry",
      "year": 1989,
      "citationCount": 473,
      "doi": "10.1016/s0021-9258(18)83106-4",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(18)83106-4",
      "verified": true
    },
    {
      "title": "Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials",
      "journal": "Journal of the American College of Cardiology",
      "year": 2009,
      "citationCount": 468,
      "doi": "10.1016/j.jacc.2008.10.008",
      "sourceUrl": "https://doi.org/10.1016/j.jacc.2008.10.008",
      "verified": true
    },
    {
      "title": "Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin",
      "journal": "JAMA",
      "year": 2021,
      "citationCount": 442,
      "doi": "10.1001/jama.2021.7444",
      "sourceUrl": "https://doi.org/10.1001/jama.2021.7444",
      "verified": true
    },
    {
      "title": "Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy",
      "journal": "Diabetologia",
      "year": 2006,
      "citationCount": 418,
      "doi": "10.1007/s00125-006-0316-2",
      "sourceUrl": "https://doi.org/10.1007/s00125-006-0316-2",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5040182038",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bf/Synthetic_Production_of_Penicillin_TR1468.jpg/330px-Synthetic_Production_of_Penicillin_TR1468.jpg"
}